202 related articles for article (PubMed ID: 37380085)
1. Biological and therapeutic viewpoints towards role of miR-218 in human cancers: Revisiting molecular interactions and future clinical translations.
Hashemi M; Gholami S; Raesi R; Sarhangi S; Mahmoodieh B; Koohpar ZK; Goharrizi MASB; Behroozaghdam M; Entezari M; Salimimoghadam S; Zha W; Rashidi M; Abdi S; Taheriazam A; Nabavi N
Cell Signal; 2023 Sep; 109():110786. PubMed ID: 37380085
[TBL] [Abstract][Full Text] [Related]
2. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents.
Hashemi M; Mirdamadi MSA; Talebi Y; Khaniabad N; Banaei G; Daneii P; Gholami S; Ghorbani A; Tavakolpournegari A; Farsani ZM; Zarrabi A; Nabavi N; Zandieh MA; Rashidi M; Taheriazam A; Entezari M; Khan H
Pharmacol Res; 2023 Jan; 187():106568. PubMed ID: 36423787
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
[TBL] [Abstract][Full Text] [Related]
4. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
[TBL] [Abstract][Full Text] [Related]
5. Glycolysis in human cancers: Emphasis circRNA/glycolysis axis and nanoparticles in glycolysis regulation in cancer therapy.
Alkhathami AG; Sahib AS; Al Fayi MS; Fadhil AA; Jawad MA; Shafik SA; Sultan SJ; Almulla AF; Shen M
Environ Res; 2023 Oct; 234():116007. PubMed ID: 37119844
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment.
Gao Y; Feng B; Han S; Lu L; Chen Y; Chu X; Wang R; Chen L
Cell Physiol Biochem; 2016; 39(6):2186-2202. PubMed ID: 27802440
[TBL] [Abstract][Full Text] [Related]
7. The promising role of miR-296 in human cancer.
Zhu L; Deng H; Hu J; Huang S; Xiong J; Deng J
Pathol Res Pract; 2018 Dec; 214(12):1915-1922. PubMed ID: 30293950
[TBL] [Abstract][Full Text] [Related]
8. A step-by-step microRNA guide to cancer development and metastasis.
Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
[TBL] [Abstract][Full Text] [Related]
9. [MiR-128, a key regulator of oncogenic properties].
Huang DQ; Guo P; Lv NH; Luo LY
Mol Biol (Mosk); 2015; 49(1):46-54. PubMed ID: 25916109
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target.
Jafarzadeh A; Paknahad MH; Nemati M; Jafarzadeh S; Mahjoubin-Tehran M; Rajabi A; Shojaie L; Mirzaei H
Biomed Pharmacother; 2022 Feb; 146():112600. PubMed ID: 34968919
[TBL] [Abstract][Full Text] [Related]
11. MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications.
Lu YF; Zhang L; Waye MM; Fu WM; Zhang JF
Exp Cell Res; 2015 May; 334(1):173-82. PubMed ID: 25857406
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-452: a double-edged sword in multiple human cancers.
Karimi Dermani F; Datta I; Gholamzadeh Khoei S
Clin Transl Oncol; 2023 May; 25(5):1189-1206. PubMed ID: 36622551
[TBL] [Abstract][Full Text] [Related]
13. Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment.
Si L; Yang Z; Ding L; Zhang D
J Cancer Res Clin Oncol; 2022 Mar; 148(3):547-564. PubMed ID: 35083552
[TBL] [Abstract][Full Text] [Related]
14. Sequence Requirements for miR-424-5p Regulating and Function in Cancers.
Xuan J; Liu Y; Zeng X; Wang H
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409396
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectives.
Zandieh MA; Farahani MH; Rajabi R; Avval ST; Karimi K; Rahmanian P; Razzazan M; Javanshir S; Mirzaei S; Paskeh MDA; Salimimoghadam S; Hushmandi K; Taheriazam A; Pandey V; Hashemi M
Pharmacol Res; 2023 Jan; 187():106582. PubMed ID: 36436707
[TBL] [Abstract][Full Text] [Related]
16. The emerging roles of the polycistronic miR-106b∼25 cluster in cancer - A comprehensive review.
Mehlich D; Garbicz F; Włodarski PK
Biomed Pharmacother; 2018 Nov; 107():1183-1195. PubMed ID: 30257332
[TBL] [Abstract][Full Text] [Related]
17. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis.
Zhang J; Zhang L; Wang J; Zhao J; Zhao X; Zhang C; Han P; Geng C
Hum Cell; 2022 May; 35(3):909-923. PubMed ID: 35179718
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of miR-375 in cancer.
Yan JW; Lin JS; He XX
Int J Cancer; 2014 Sep; 135(5):1011-8. PubMed ID: 24166096
[TBL] [Abstract][Full Text] [Related]
20. The dual role of microRNA (miR)-20b in cancers: Friend or foe?
İlhan A; Golestani S; Shafagh SG; Asadi F; Daneshdoust D; Al-Naqeeb BZT; Nemati MM; Khalatbari F; Yaseri AF
Cell Commun Signal; 2023 Jan; 21(1):26. PubMed ID: 36717861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
